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Abstract. Previously we have shown that PDGF recep- 
tor mutants that do not bind PI-3 kinase internalize af- 
ter ligand binding, but fail to downregulate and de- 
grade. To define further the role of PI-3 kinase in 
trafficking processes in mammalian cells, we have in- 
vestigated the effects of a potent inhibitor of PI-3 ki- 
nase activity, wortmannin. At nanomolar concentra- 
tions, wortmannin inhibited both the transfer of PDGF 
receptors from peripheral compartments to juxtanu- 
clear vesicles, and their subsequent degradation. In 
contrast, the delivery of soluble phase markers to lyso- 
somes, assessed by the accumulation of Lucifer yellow 
(LY) in perinuclear vesicles after 120 min of incuba- 
tion, was not blocked by wortmannin. Furthermore, 
wortmannin did not affect the rate of transferrin up- 
take, and caused only a small decrease in its rate of re- 
cycling. Thus, the effects of wortmannin on PDGFr 
trafficking are much more pronounced than its effects 
on other endocytic events. Unexpectedly, wortmannin 
also caused a striking effect on the morphology of en- 
dosomal compartments, marked by tubulation and en- 
largement of endosomes containing transferrin or LY. 
This effect was somewhat similar to that produced by 
brefeldin A, and was also blocked by pre-treatment of 
cells with aluminum fluoride (A1F4-). These results 
suggest two sites in the endocytic pathway where PI-3 
kinase activity may be required: (a) to sort PDGF re- 
ceptors from peripheral compartments to the lysosomal 
degradative pathway; and (b) to regulate the structure 
of endosomes containing lysosomally directed and re- 
cycling molecules. This latter function could be medi- 
ated through the activation of A1F4--sensitive GTP- 
binding proteins downstream of PI-3 kinase. 
p 
l-3 kinase was first discovered as an activity in im- 
munoprecipitates of receptor and nonreceptor ty- 
rosine kinases that phosphorylated the 3' position 
of the inositol ring in Pins, Plns(4)P, and Plns(4,5)P2 (37). 
The association of this lipid kinase activity with receptors 
that stimulate cellular growth suggested a role for PI-3 ki- 
nase in mitogenic signaling (3). More recently, the exist- 
ence of several biochemically distinct PI-3 kinases in mam- 
malian cells has been reported (32,  33),  and PI-3 kinase 
activity has  been  implicated  in  numerous  cellular  pro- 
cesses including membrane ruffling, chemotaxis, traffick- 
ing of membrane proteins, and activation of kinases such 
as protein kinase C (reviewed in reference 19). Thus, PI-3 
kinases  in  mammalian cells  have  emerged  as  a  diverse 
family of proteins that are likely to be involved in multiple 
essential cellular processes. 
In  yeast, deletions  or  mutations  in  the  VPS34  gene, 
which encodes for the only detectable PI-3 kinase activity 
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in these ceUs (31), lead to a dramatic alteration in the sort- 
ing of newly synthesized proteins to the yeast vacuole (13, 
14, 31), and to a deficiency in the degradation of internal- 
ized a  factor receptors  (23).  Thus, in yeast, PI-3  kinase 
regulates protein sorting events in the secretory and prob- 
ably in the endocytic pathways. We have proposed that 
this sorting function of P1-3 kinase has been conserved in 
evolution, based on studies of mutant PDGF receptors im- 
paired in PI-3 kinase binding, which are altered in posten- 
docytic sorting to a degradative pathway (16, 17). The spe- 
cific mechanism whereby PI-3 kinase activity is required 
for PDGF receptor trafficking is not known. 
Recently it has  been  discovered that  a  potent fungal 
toxin, wortmannin, is a highly specific, potent inhibitor of 
the catalytic pll0 subunit of mammalian PI-3 kinase (24, 
40). Wortmannin rapidly and irreversibly inhibits P1-3 ki- 
nase catalytic activity in intact cells with an 1D50 of 5-10 
nM. At these concentrations, wortmannin does not inhibit 
any other known protein or lipid kinase activities in cells. 
The specificity and potency of wortmannin has made it a 
widely utilized tool to dissect the cellular functions of PI-3 
kinase (5, 25). We have used wortmannin to explore fur- 
ther the role of PI-3 kinase on endocytic trafficking pro- 
cesses in mammalian cells. 
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wortmannin on the trafficking of three markers of the en- 
docytic pathway: transferrin, which internalizes and recy- 
cles through a well-characterized pathway involving sort- 
ing  and  recycling  endosomes  (15,  22),  Lucifer  yellow 
(LY),  1 a fluid phase marker which traffics to the lysosomal 
pathway, and the PDGF receptor (PDGFr), a transmem- 
brane protein which normally does not recycle, but is in- 
stead delivered to the lysosome for degradation. The re- 
suits  presented  here  support  the  hypothesis  that  PI-3 
kinase plays a critical role in the sorting of the PDGFr ty- 
rosine kinase to the lysosomal pathway. Moreover, an un- 
expected role for PI-3 kinase in the control of membrane 
organelle  structure is  suggested  by a  dramatic  effect of 
wortmannin on the morphology of endocytic organelles. 
Materials and Methods 
Cells 
Human HepG2  cells transfected with  human 13-PDGF  receptors  (36), 
HeLa cells, and COS-7 cells were grown on glass coverslips or on 60 mm 
dishes to 80%  confluence in DME supplemented with fetal calf serum 
(10%) (Upstate Biotechnology, Inc., Lake Placid, NY). In experiments in- 
volving fluid phase or transferrin uptake, cells were serum deprived for 2 
or 18 h with no detectable difference in the results obtained. For experi- 
ments in which PDGFr  internalization was analyzed, cells were serum 
starved for 18 h, 
Immunofluorescence 
Cells were incubated at 37°C with PDGF-BB (20-50 ng/ml) (Upstate Bio- 
technology, Inc.) for the times indicated in each experiment. Cells were 
rapidly washed twice in ice-cold PBS, and fixed in 4% formaldehyde for 
15 min at room temperature. Cells were washed four times with PBS, and 
permeabilized by immersion in methanol at -20°C for 6 rain. Coverslips 
were  briefly  air dried,  and  stained with a  monoclonal antibody raised 
against the receptor extracellular domain (PDGFR2; Oncogene Sciences, 
Mineola, NY),  and goat antibodies to mouse IgG  coupled  to  FITC or 
Rhodamine (Tago, Inc., Burlingame, CA). The fluid phase pathway was 
visualized by incubating cells with Lucifer yellow (5 mg/ml in DME) (Mo- 
lecular Probes, Eugene, OR) for the times indicated. Cells were then fixed 
and permeabilized as described above, and the LY signal was enhanced by 
staining with an anti-LY polyclonal antibody (Molecular Probes) and goat 
antibodies to rabbit IgG coupled to FITC. The transferrin pathway was vi- 
sualized by incubation of cells with Texas red-labeled transferrin (1 p.g/ml 
in DME) (Molecular Probes), for the times indicated in each experiment, 
followed by fixation in 4 % formaldehyde for 15 rain at room temperature. 
Staining for  13COP  and clathrin was done using rabbit  antisera raised 
against 13COP (kindly provided by Dr. R. Klausner, NICHD, Bethesda, 
MD) or antisera raised against the COOH-terminal 15 amino acids of the 
clathrin heavy chain (18). Cells were mounted and visualized on a Zeiss 
IM-35 microscope, using a  Nikon Apo 100/1.3  oil immersion lens. Data 
were recorded using a charge-coupled device (CCD) camera (Photomet- 
rics Ltd., Tucson, AZ) and visualized on a Silicon Graphics 4D/240 GTX. 
Where indicated, images were optically sectioned using digital imaging 
microscopy and a deconvolution algorithm that reverses the blurring in- 
troduced by the microscope optics (4). In these experiments, 20--30 serial 
two-dimensional images were recorded at 0.25-ram intervals using a thermo- 
electrically cooled CCD camera (Photometrics Ltd.). Each image was cor- 
rected for lamp intensity variations and photobleaching. Blurring of fluo- 
rescence from regions above and below the plane of focus was reversed 
using an  iterative  deconvolution algorithm based on  the theory of ill- 
posed problems (4). 
Transferrin Uptake and Recycling 
125I-transferrin  (31,000 cprn/l~g)  was prepared using 10 i~g diferric trans- 
1. Abbreviations used in thispaper. BFA, brefeldin A; LY, Lucifer yellow; 
PDGFr, PDGF receptor; Tf, transferrin; TR, Texas red. 
ferrin (Boehringer-Mannheim Biochemicals, Indianapolis, IN) and Bol- 
ton Hunter reagent (Amersham, Arlington Heights, IL). To measure the 
rate of transferrin uptake, ceils were grown to 80% confluence in 24-well 
multiwell dishes. Endogenous transferrin was removed by two sequential 
40-min incubations in serum-free DME. Ceils were then incubated in 500 
p,1 of DME containing 0.2 ixg/ml  125I-transferrin  for the times indicated. 
Ceils were washed four times in 1 ml of ice-cold PBS, and solubilized in 
0.1% SDS. Radioactivity in the lysates was measured by gamma counting. 
Nonspecific uptake was determined in incubations containing nonlabeled 
transferrin (10 ~g/ml). For the measurement of transferrin recycling, cells 
were incubated with 0.2 p,g/ml ~2~I-transferrin  for 60 min, and washed four 
times in ice-cold PBS. Recycling was initiated by adding DME at 37°C 
containing  nonlabeled  transferrin  (10  /~g/ml).  At  the  times  indicated 
monolayers were washed four times with 1 ml of ice-cold PBS, and solubi- 
lized in 0.1% SDS. Radioactivity in the lysates was measured by gamma 
counting. 
Measurement of Phosphoinositide  Levels 
Cells were grown in 100 mm dishes to 70-80% confluency, and labeled by 
incubation for 3 h at 37°C in Krebs-Ringer/Hepes buffer containing 2 mM 
sodium pyruvate, 2% BSA and 0.5 mCi/ml of [32p]orthophosphate (New 
England Nuclear, Boston, MA). Cell monolayers were washed three times 
with ice-cold PBS, and rapidly scraped into 750 ~1 of MeOH/1 M HC1 (1:1). 
Lipids were extracted with 400 Ixl of CHC13, deacylated, and analyzed by 
HPLC as described (1). 
Receptor Degradation 
Cells were grown to 80% confluence in 60 mm culture dishes, and incu- 
bated for 18 h in serum-free, methionine-free DME containing [35S]me- 
thionine (100 p.Ci/ml; Amersham) plus bovine serum albumin (1%), and 
then for 45 rain in DME containing bovine serum albumin (1%) and me- 
thionine (0.3 mg/ml; DME-BSA). Cells were then incubated without or 
with PDGF-BB (50 ng/ml) (Upstate Biotechnology, Inc.) for 2 h. Where 
indicated, wortmannin, brefeldin A  (BFA), or a  mixture of both toxins 
was added 10 rain before addition of PDGF. Cells were washed twice in 
ice-cold PBS, and lysed in 800 Ixl of a buffer containing 20 mM Tris (pH 
8.0), 150 mM sodium chloride, 1% Triton X-100, 1% sodium deoxycho- 
late, 0.1%  SDS, 2 mM phenyl-methyl-sulfonyl fluoride, 1 mM benzami- 
dine, 1 mM 1,10 phenanthroline, 10 l~g/ml leupeptin, and 1 mM sodium 
vanadate  (Sigma  Chemical  Co.).  Receptors  were  immunoprecipitated 
with a polyclonal antibody to ct- and 13-PDGF receptors (Upstate Biotech- 
nology, Inc.), resolved on 7.5% polyacrylamide gels, transferred to nitro- 
cellulose, and exposed to autoradiographic film for 48 h. 
Effects of Wortmannin and BFA 
Wortmannin (Sigma Chemical Co.) was dissolved in DMSO to a final con- 
centration of 10 mM, dispensed into 5-1xl aliquots and stored at  -80°C. 
Wortmannin aliquots were thawed and diluted 1:1,000 in ice-cold PBS to a 
final concentration of 10 p,M. Aliquots from this diluted stock were added 
directly to the cells to achieve the final concentrations indicated in each 
experiment. Because wortmannin is photosensitive and unstable in aque- 
ous solutions, it was routinely thawed, diluted, and added to cells within 
10 rain. Thawed aliquots were discarded. BFA (Sigma Chemical Co.) was 
dissolved in ethanol to a final concentration of 50 raM. Aliquots from this 
stock were added directly to the cells to achieve the final concentration in- 
dicated in each experiment. 
Results 
Pathway of Internalization of Wild-type  and Mutant 
PDGF Receptors 
Previously we have found that PDGFr containing muta- 
tions which specifically impair PI-3 kinase binding can in- 
ternalize, but fail to undergo down-regulation and degra- 
dation  in  response  to PDGF (17).  To better define the 
steps  after internalization where PI-3 kinase is required 
for PDGFr down-regulation, we initiated studies to define 
the trafficking pathway of PDGFr from the cell surface to 
lysosomes. The intracellular localization of both wild-type 
The Journal of Cell Biology, Volume 132, 1996  596 Figure 1.  Internalization of PDGF receptors and LY. Cells were 
simultaneously  exposed to PDGF (20 ng/ml)  and to LY (5 mg/ 
ml). After the indicated  times of incubation  at 37°C, cells were 
fixed, permeabilized, and stained for LY (bottom) and PDGF re- 
ceptors (top) using specific polyclonal  and monoclonal antibod- 
ies,  respectively.  Secondary  antibodies  labeled  with  FITC  or 
rhodamine were used to detect the polyclonal or monoclonal an- 
tisera,  respectively.  Arrowheads point to vesicular structures la- 
beled both with LY and PDGFr. Bars, 10 ~m. 
and mutant PDGFr was compared with that of LY, a lyso- 
somally directed fluid phase marker (Figs.  1 and 3), and 
that of transferrin (Tf), a marker for a well-characterized 
recycling pathway (see Figs. 2 and 4). 
HepG2  cells  expressing  wild-type  receptors  were  ex- 
posed to PDGF  and  either LY (Fig.  1)  or Tf (Fig. 2)  at 
37°C  for the  times  indicated.  Cells  were  fixed  and  pro- 
cessed for immunofluorescence as described in Materials 
and Methods. As early as 10 rain after exposure of cells to 
PDGF, some colocalization of PDGFr and  LY could be 
detected (Fig. 1, left). After 30 min, the PDGFr was found 
in  larger, more  perinuclear vesicles, and  the  co-localiza- 
tion  with  the  fluid  phase  marker was  very pronounced 
(Fig. 1, middle). After 120 min, much of the receptor signal 
disappeared  due  to  lysosomal degradation,  whereas  the 
pericentriolar LY staining remained very intense  (Fig.  1, 
right). 
In contrast, at this level of resolution, a precise co-local- 
ization between the PDGFr and transferrin could not be 
detected at any time (Fig. 2). After 20-30 min of internal- 
ization, both PDGFr and transferrin were concentrated in 
a  perinuclear region (Fig. 2, middle and right). However, 
transferrin was localized in more diffuse tubulo-vesicular 
structures which were clearly distinct from the larger vesi- 
cles containing  PDGFr. These tubulo-vesicular elements 
probably correspond to the recycling endosome (15, 22). 
These results suggest that wild-type PDGFr molecules are 
sorted  from recycling molecules relatively quickly  (0-30 
min) after internalization, but continue to co-localize with 
lysosomally destined fluid-phase markers (Fig. 1). 
In marked contrast to the wild-type receptor, mutant re- 
ceptors which  lack PI-3 kinase binding sites (F40/51)  re- 
mained at the cell periphery even after 30-90 min of incu- 
Figure 2.  Internalization  of PDGF  receptors  and  transferrin. 
Cells  were  simultaneously  exposed  to  PDGF  (20  ng/ml)  and 
Texas  red-labeled  transferrin  (5  p~g/ml). After  the  indicated 
times of incubation  at 37°C, cells were washed, fixed, and stained 
with anti-PDGF receptor monoclonal antibodies,  and FITC-cou- 
pied anti-mouse secondary antibodies.  Despite the appearance 
of both transferrin and PDGF receptors in the same general vicin- 
ity (arrows), no precise co-localization was observed. Bars, 10 p,m. 
bation  with  PDGF  (Fig.  3).  These  receptors  were 
visualized  in  diffuse,  peripheral  structures,  close  to  the 
plasma membrane (Fig. 3, top). In contrast to wild-type re- 
ceptors (Fig. 1) the F40/51 mutant displayed little co-local- 
ization with LY (Fig.  3,  left).  Interestingly, although  the 
F40/51 mutant recycles to the cell surface after internaliza- 
tion  (17),  the mutant displayed little co-localization with 
the pericentriolar transferrin (Fig. 3, right), suggesting that 
the recycling of PDGFr mutants to the cell surface takes 
place through a  pathway that does not involve the trans- 
ferrin recycling compartment. The peripheral localization 
of the  receptor  mutants,  and  their  failure  to  co-localize 
with the bulk of the LY or Tf signals, suggest that recep- 
tors impaired in PI-3 kinase binding are arrested in their 
trafficking at an early step after endocytosis. 
Effects of Wortmannin on PDGF Receptor and 
L Y  Trafficking 
To test further whether the differences between the traf- 
ficking pathways  of wild-type  and  mutant  PDGFr  were 
due to differences in PI-3 kinase catalytic activity associ- 
ated with the receptor cytoplasmic domain, we analyzed 
the effects of wortmannin, a  potent and specific inhibitor 
of PI-3 kinase. Cells were incubated without or with wort- 
mannin (50 riM) for 15 min, and then exposed to PDGF 
and LY. After 30 min of exposure of wortmannin-treated 
cells to PDGF, the receptor was found in a diffuse, periph- 
eral localization (Fig. 4, top right), which contrasted mark- 
edly with  the  vesicular,  pericentriolar  localization  of re- 
ceptors in nontreated cells (Fig. 4, top left). Furthermore, 
the marked co-localization of PDGFr with LY (Fig. 4, top 
and bottom left) was lost in wortmannin-treated cells (Fig. 
4, top and bottom right). These results are similar to those 
obtained studying PDGFr mutants impaired in PI-3 kinase 
Shpetner et al. PI-3 Kinase in Endocytosis  and Endosome  Structure  597 Figure 3.  Internalization of F40/51 PDGF receptor mutants, LY, 
and transferrin. Cells expressing mutant (F40/51) receptors were 
incubated with PDGF and  LY (left) or PDGF and  transferrin 
(right) for 30 min at 37°C. Cells were fixed, and internalized mol- 
ecules visualized  as described in Figs.  1 and 2. Arrows point to 
the peripheral structures containing most of the mutant PDGFr 
(top). The asterisk in the top right panel was placed in the peri- 
centriolar region containing the bulk of transferrin, to emphasize 
the lack of co-localization between PDGFr and the recycling en- 
dosome. Arrowheads point to internalized LY (bottom  left) and 
transferrin (bottom right). Bars, 10 txm. 
binding (Fig. 3), and suggest that PI-3 kinase catalytic ac- 
tivity is required for PDGFr sorting from a specific periph- 
eral compartment to later steps in the lysosomal pathway. 
An unexpected finding in these studies was that, in addi- 
tion to causing a retention of PDGFr in a peripheral com- 
partment,  treatment  of cells  with  wortmannin  caused  a 
pronounced change in the morphology of endosomes con- 
taining  LY  (Fig.  4,  bottom  right).  This  morphological 
change  consisted  in  the  appearance  of a  tubulated  net- 
work, which in many cells almost completely replaced the 
vesicular structures containing LY. In addition to the ap- 
pearance of interconnected tubules,  the amount of LY in 
wortmannin-treated  cells appeared to be higher than that 
in  untreated  cells  at  early  time  points  (Fig.  5,  bottom). 
These  alterations,  however,  did  not  appear  to block the 
trafficking of LY to lysosomes, as a marked accumulation 
Figure 4.  Effect of wortmannin on PDGF receptor and LY inter- 
nalization. Cells were incubated without (control) or with (WTM) 
wortmannin (50 nM) for 10 min, and then exposed to PDGF and 
LY for 30 min. Cells were fixed, and internalized molecules visu- 
alized as described in Figs. 1 and 2. Note the precise co-localiza- 
tion of PDGFr and LY in the left panels (arrowheads), which is 
not apparent in wortmannin-treated cells in the right panels (ar- 
rowheads), and the  appearance  of interconnected tubules con- 
taining LY in response to wortmannin (bottom right). 
of the marker in large perinuclear vesicles was clearly visi- 
ble after 120 min of incubation (Fig. 5, extreme right). 
Effects of Wortmannin  on the Transferrin 
Internalization  Pathway 
To determine  whether  the morphological effect of wort- 
mannin was restricted to endosomes labeled by LY, we an- 
alyzed the effects of the toxin on the transferrin pathway. 
Analysis of endosomes containing Texas red (TR)-transfer- 
fin in HepG2 cells, monkey COS-7 cells, and human Hela 
cells also revealed a pronounced effect of wortmannin on 
endosome  morphology (Fig.  6).  In nontreated  cells  TR- 
transferrin was distributed throughout the cell in a distinct 
punctate pattern, with an area of concentration in the jux- 
tanuclear region which represents the recycling endosome 
(15,  22).  In cells  treated  with  wortmannin  a  striking  in- 
crease in size, and decrease in number, of endosomes was 
observed  (Fig.  6, broken  arrow).  Also apparent  in many 
cells was the presence of fine tubules elongated from these 
enlarged endosomes  (Fig.  6, arrows).  The effect of wort- 
mannin was observed at concentrations  as low as 10 nM, 
and was maximal at 50 nM (not illustrated). 
The effect of wortmannin  occurred very rapidly, being 
detectable  as early as 5 min after exposure of cells to the 
toxin (Fig. 7). After 20 min, a virtually complete transfor- 
mation of endosomes containing transferrin (Fig. 7) or LY 
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nin  on  the  internalization  of 
LY. Cells were incubated with- 
out  (control)  or with  (WTM) 
wortmannin  (50  riM)  for  10 
rain,  and  exposed  to  LY  for 
the  times  shown.  Cells  were 
fixed and LY visualized  as de- 
scribed in Fig.  1. Arrowheads 
are aligned along extended tu- 
bules, and arrows point to jux- 
tanuclear  vesicular  structures 
apparent at later time points. 
(not shown)  into an interconnected  tubular network  was 
apparent  in  many cells.  To determine  whether  the  mor- 
phological changes induced by wortmannin would result in 
functional alterations in trafficking, we measured the rates 
of uptake  and recycling of 125I-transferrin  (Fig. 8). Treat- 
ment of cells with wortmannin had no detectable effect on 
the  rate  of accumulation  of 125I-transferrin  (Fig.  8,  left). 
However, the rate of recycling was altered by wortmannin 
(Fig.  8,  right).  Whereas  the  rate  of transferrin  recycling 
measured in the first 10 rain of the release assay appeared 
unaltered  by wortmannin,  the  amount  of transferrin  re- 
leased subsequent to 10 min appeared to be decreased by 
30-40%  in  wortmannin-treated  cells.  After  40-50  min, 
however,  all  labeled  transferrin  was  released  from both 
untreated and wortmannin-treated cells. These results sug- 
gest that release  of transferrin  out of a  specific compart- 
ment in the recycling pathway is  slowed by wortmannin. 
Because  the  rates  of transferrin  and  lipid  recycling  are 
similar (22), a decrease in transferrin recycling may reflect 
a  general  decrease  in  the  rate  of membrane  flow out of 
early or recycling endosomes in response to wortmannin. 
This decrease could lead to the increased accumulation of 
LY and to the  apparent  enlargement  of endosomes con- 
taining transferrin observed after treatment with the toxin 
(Figs. 5-7). 
The inhibition of PDGFr trafficking and the changes in 
organelle  morphology produced  by  wortmannin  suggest 
that  PI-3 kinase  activity is  required  for at least  two pro- 
cesses in the endocytic pathway: (a) to sort PDGFr out of 
a  peripheral,  postendocytic compartment  into  later  steps 
in the endocytic pathway; and (b) to regulate both the ki- 
netics  of membrane  flow  and  the  morphology of endo- 
somes containing lysosomally directed and recycling mole- 
cules. 
Figure 6.  Effects of wortman- 
nin  on  endosomes  containing 
transferrin.  HepG2,  COS-7, 
and HeLa cells were incubated 
with  Texas  red-transferrin  (5 
p.g/ml)  for  30  min  at  37°C. 
Wortmannin  (bottom)  was 
added  to  the  medium  to 
achieve  a  final  concentration 
of  50  nM,  and  incubations 
were continued for a further 20 
min.  Cells  were washed twice 
in  ice-cold PBS,  fixed in  4% 
formaldehyde,  and  visualized. 
Images comprise an individual 
optical section from the middle 
of the cell after restoration, as 
described  in  Materials  and 
Methods. Arrowheads and ar- 
rows point  to  enlarged  endo- 
somes and tubulated structures 
found  in  wortmannin-treated 
cells. Bars, 10 ~m. 
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effect of wortmannin on endo- 
somes  containing  transferrin. 
HepG2  ceils  were  incubated 
with TR-transferrin for 50 min 
at 37°C, Wortmannin (50 nM) 
was  present for the last  5, 10, 
or 20 min of incubation as indi- 
cated. Ceils were washed twice 
in  ice-cold PBS,  fixed  in  4% 
formaldehyde, and  visualized. 
Images are the sum of 20 indi- 
vidual optical sections  compris- 
ing the middle  of the cell after 
restoration,  as  described  in 
Materials and Methods. 
Effects of Wortmannin on Endogenous 
Phosphoinositide Levels 
An important question raised by these findings is whether 
specific phosphoinositide products of PI-3 kinases  are in- 
volved in  mediating  both receptor  sorting  and organelle 
morphology in the endocytic pathway. To begin to address 
this question, we measured the levels of endogenous phos- 
phoinositides  in  cells  grown  and  treated  exactly  as  de- 
scribed  in  the  experiment  shown  in  Fig.  7.  Under  these 
conditions,  cells  are  exponentially  growing,  and  are  de- 
prived of serum for only 2-3 h. The levels of endogenous 
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Figure 8.  Effects of wortmannin on the internalization and recy- 
cling of transferrin.  (Left) HepG2 cells  were exposed to wort- 
mannin (50 nM) for 10 rain,  and then to 125I-transferrin. Wort- 
mannin (WTM) was present throughout the incubation. At the 
times indicated, cells were washed, and internalized radioactivity 
measured. (Right) Cells  were incubated with 125I-transferfin for 
60 min, and then exposed to wortmannin for 10 rain.  Ceils were 
then washed three times with ice-cold PBS, and placed in media 
at 37°C containing excess unlabeled transferrin, in the absence or 
presence of wortmannin (WTM). After the times indicated, the 
radioactivity remaining associated with the cells was quantified. 
Plotted are the means _+ SEM of three experiments performed in 
triplicate, 
phosphoinositides in these cells are shown in Table I. The 
most  abundant  3'-phosphoinositide  was  Plns(3)P,  which 
comprised ~75 % of the total pool of 3'-phosphoinositides. 
Within 5 min of exposure  of cells to 50 nM wortmannin, 
the levels of Plns(3)P decreased by 70%, but remained un- 
changed thereafter. In contrast, the levels of Plns(3,4,5)P3 
decreased by 50% after 5 min of exposure to wortmannin, 
and were undetectable after 10 min of incubation with the 
toxin.  Interestingly, the  levels of Plns(3,4)P2  did not de- 
crease  in  response  to wortmannin.  These  results  suggest 
that under conditions of exponential growth, 30% of cellu- 
lar Plns(3)P,  and most of the cellular pool of Plns(3,4)P2 
are generated by wortmannin-insensitive PI-3 kinase/s. 
Similarities and Differences between the Effects of 
Wortmannin and BFA 
The tubutation  of endosomes caused by wortmannin was 
reminiscent of the extensively reported effect of BFA (21, 
38), which causes the extension of long, interconnected tu- 
Table L Time Course of  the Effects of Wonvru~nin on the Levels 
of  Endogenous Phosphoinositides in Rapidly Growing HepG2 
Cells 
Time  PIns(3)P  PIns(3,4)P2  Plns(3,4,5)P3  Plns(4)P  Plns(4,5)P2 
min 
0  13,053  2,706  1,172  527,060  1,027,909 
5  4,517  5,560  570  452,303  977,197 
10  4,533  3,102  0  537,946  1,021,332 
20  4,732  5,101  0  478,838  1,063,518 
Exponentially growing cells were labeled with [32p]orthophosphate for 2 h as de- 
scribed in Materials and Methods, and treated with wortmannin (50 nM) for the times 
indicated. Monolayers were then scraped off the culture dishes, and lipids extracted, 
deacylated and separated by HPLC as described (1). The radioactivity in each deacyla- 
tion product was expressed as total cpndpeak. The experiment was repeated twice with 
indentical qualitative results. Shown are the averaged raw values from these two inde- 
pendent experiments, which varied by ~20%. 
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anism whereby BFA elicits these morphological changes 
has been partially elucidated, and appears to involve an in- 
hibition  of cytosolic-coat assembly. We  reasoned  that  a 
comparison of the effects of wortmannin and BFA on en- 
docytic  organelle  structure  and  function  might  suggest 
mechanisms whereby wortmannin,  and  thus  PI-3 kinase, 
function  in  the  endocytic  pathway.  Therefore,  we  com- 
pared the effects of these toxins on cytosolic-coat protein 
assembly (Fig. 9), PDGFr trafficking (see Figs. 10 and 11), 
and endosome morphology (see Figs. 12 and 13). 
To determine whether wortmannin, like BFA, would af- 
fect the assembly of known cytosolic coats, the distribution 
of [3COP, clathrin, and ~/-adaptin were compared (Fig. 9). 
BFA blocked the assembly of coatomer, as evidenced by 
the change in the distribution of 13COP from a tightly con- 
centrated juxtanuclear structure to a disperse distribution 
(Fig. 9, middle). BFA also blocked the assembly of ~/-adap- 
tin at the TGN (29), as evidenced by the loss of ~/-adaptin 
and clathrin staining in a distinctly concentrated area next 
to the nucleus (Fig. 9, bottom and top). In contrast, wort- 
mannin  had  no  detectable  effects on  the  distribution  of 
clathrin,  13COP, or "v-adaptin (Fig. 9, compare columns C 
and  WTM).  Similar results were  observed at  concentra- 
tions of wortmannin up to 500 nM (not shown). These re- 
sults indicate that unlike  BFA, wortmannin does not in- 
hibit  the  assembly  of  cytosolic  coats  in  the  secretory 
pathway.  In  addition,  wortmannin  had  no  effect on  the 
ability of BFA to cause disassembly of coat components 
(not shown). Thus, the effects of wortmannin appear to be 
restricted to the endocytic pathway. One possible reason 
for this selectivity could be the presence, in the secretory 
pathway, of specific PI-3 kinase isoforms that are less sen- 
sitive to inhibition by wortmannin (reference 32; and Table I). 
The effects of BFA and wortmannin on the subcellular 
localization  and  degradation  of PDGFr  were  compared 
(Fig.  10).  Cells were left untreated  (Fig.  10,  top  left and 
right)  or treated for 10 min with wortmannin (bottom left) 
or BFA (bottom  right)  and then  exposed to PDGF  (top 
right and bottom)  for 60 min (Fig.  10).  Both in the pres- 
ence  or  absence of BFA  receptors moved from the  cell 
surface to large juxtanuclear vesicles (Fig. 10, right).  Some 
tubulated structures containing PDGFr could be detected 
in  BFA:treated  cells  (Fig.  10,  bottom  right),  suggesting 
that,  like  other  markers  of the  lysosomal pathway  (39) 
PDGFr can exit the tubulated endosomal system induced 
by BFA. In contrast, in cells treated with wortmannin the 
movement  of  receptors  from  peripheral  structures  into 
pericentriolar vesicles was blocked (Fig.  10,  bottom  left). 
Addition  of both toxins together blocked PDGFr move- 
ment to pericentriolar vesicles, indicating that BFA does 
not reverse the inhibitory effects of wortmannin on recep- 
tor trafficking (not shown). Furthermore, BFA had no sig- 
nificant  effect  on  PDGF-indueed  receptor  degradation 
(Fig.  11,  BFA),  whereas wortmannin  fully inhibited  this 
process (Fig. 11, WTM). Taken together, the results shown 
in Figs. 11 and 12 indicate that the alterations of organelle 
structure induced by BFA do not per se block PDGFr traf- 
ficking. Furthermore, these results suggest that the effects 
of wortmannin on organelle structure and PDGFr traffick- 
ing are independent. 
The results shown above indicate two important differ- 
ences between the effects of wortmannin and BFA; the ef- 
fects of the former appear to be restricted to the endocytic 
pathway,  and  they  also  include  an  inhibition  of PDGFr 
sorting probably resulting from inhibition of PI-3 kinase 
activity bound to the PDGFr cytoplasmic domain. Never- 
theless, both wortmannin and BFA cause tubulation of or- 
Figure  9.  Effects  of  wort- 
mannin and BFA on cytoso- 
lic coat distribution.  HepG2 
cells  were  treated  with  10 
txM  BFA  (BFA),  50  nM 
wortmannin  (WTM),  or 
nothing (C) for 10 rain. Cells 
were  fixed,  permeabilized, 
and  incubated  with  rabbit 
polyclonal  antibodies  against 
either  the  clathrin  heavy 
chain  (Chc)  (top)  or  [3COP 
(middle)  or  with  a  mouse 
monoclonal antibody against 
-¢-adaptin (bottom).  Primary 
antibodies  were  detected 
with FIT@labeled secondary 
antibodies  against  rabbit  or 
mouse  immunoglobulins 
(Tago).  Shown in each panel 
is  one  section  through  the 
middle of the cell after resto- 
ration. Bars, 15 ixm. 
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distribution. HepG2 cells were treated with nothing (top left), 50 
nM wortmannin (bottom left), 50 p.M brefeldin-A (bottom right) 
for 10 min, and then exposed to PDGF (20 ng/ml) for 60 min at 
25°C (top right and bottom). Cells were fixed, permeabilized, and 
stained with a monoclonal antibody against the PDGF receptor 
and anti-mouse immunoglobulins coupled to FITC. Arrowheads 
indicate juxtanuclear vesicles, and arrows indicate tubular struc- 
tures containing PDGFr. Bars, 10 I~m. 
Figure 11.  Effects  of  wort- 
mannin  and BFA on PDGF 
receptor degradation. HepG2 
cells expressing the wild-type 
PDGF receptor were labeled 
with [35S]methionine,  and in- 
cubated  for  2  h  in  the  ab- 
sence (-) or presence (+) of 
PDGF  (50  ng/ml).  BFA 
(BFA) (50 p.M) or wortman- 
nin  (50 nM)  were  added 10 
min  before  exposure  to 
PDGF.  Receptor  immuno- 
precipitates were resolved on 
SDS-PAGE, and exposed to 
autoradiographic  film.  The 
expected  position  of  the 
PDGF receptor is indicated 
with  an  arrow.  Bars  repre- 
sent  the  means  _+  SEM  of 
densitometric  scans  ob- 
tained from five independent 
experiments. 
later steps in the lysosomal degradative pathway. This ar- 
rest in trafficking is also observed when  PDGFr mutants 
impaired in PI-3 kinase binding are analyzed. Thus, it ap- 
pears likely that the association of PI-3 kinase activity with 
the PDGFr cytoplasmic domain is necessary for its transit 
from a  peripheral, early endocytic compartment  into the 
lysosomal degradative pathway. Second, wortmannin causes 
a dramatic alteration in the morphology of endosomal ele- 
ments containing transferrin and fluid phase markers. This 
latter effect is similar to that induced by the fungal toxin 
ganelles  in  the  endocytic pathway.  The  effects  of  BFA 
have been shown to be blocked by ALF4-, which inhibits 
the hydrolysis of GTP bound to ARF proteins, and results 
in a persistent activation of ARF and a concomitant stabi- 
lization of cytosolic coats on membranes (9, 21). To deter- 
mine whether similar mechanisms might be involved in the 
effects of wortmannin and BFA on organelle morphology, 
we compared their sensitivity to ALF4-. 
Within 10 min of exposure of HepG2 cells to wortman- 
nin  or BFA, tubules  containing transferrin could be ob- 
served  (Fig.  12,  arrowheads).  The  tubulated  pattern  in- 
duced by wortmannin was different from that of BFA in 
that  condensation  of endosomes  was  more  pronounced, 
and tubules appeared to be shorter than those induced by 
BFA. However, the effects of both wortmannin and BFA 
were  similarly  blocked  by  pre-treatment  of  cells  with 
ALF4- (30 mM NaF +  50 IxM AICI3). Similarly, the effect 
of wortmannin  on  endosomes  containing  LY  was  com- 
pletely blocked by pre-treatment with ALF4- (Fig. 13). 
Discussion 
In this paper we have shown that wortmannin causes two 
distinguishable effects on trafficking in the endocytic path- 
way in mammalian cells. First, it appears to block the tran- 
sit of activated PDGFr from a  peripheral compartment to 
Figure 12.  The effects of wortmannin and BFA on endosomes 
containing transferrin are blocked by ALF4-. HepG2 ceils were 
incubated with TR-transferrin for 30 min. ALF4- (30 mM NaF + 
50 p.M AICI3) was then added ( +ALF4-  ), and incubations contin- 
ued for 5 min. Wortmannin (bottom)  or BFA (top) were then 
added at a final concentration of 50 nM or 50 pLM, respectively. 
After an additional 20 rain, cells were washed three times in ice- 
cold PBS, fixed in formaldehyde and visualized. Arrowheads in- 
dicate tubular structures,  and  arrows point to  enlarged endo- 
somes observed in response to wortmannin or BFA. Bars, 10 p.M. 
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mannin on LY-containing  en- 
dosomes  are  blocked  by 
ALF4-.  Cells  were  incubated 
for 20 min with LY, and then 
for 5 min in the absence (left 
and middle) or presence (right) 
of ALF4-  (30 mM NaF +  50 
IxM  AIC13).  Wortmannin 
(WTM)  (50  nM)  was  then 
added (middle and right), and 
after 15  min  cells  were  fixed 
and  stained  as  described 
above. Arrows point to vesicu- 
lar  structures  containing  LY, 
and arrowheads are aligned on 
tubulated structures which ap- 
pear in response to wortmannin. 
BFA, and  can also be blocked by pre-treatment of cells 
with  ALF4-.  These  results  suggest  the  hypothesis  that 
ALF4- sensitive GTP-binding proteins may operate down- 
stream of PI-3 kinase. 
Points in the Endocytic Pathway Where PI-3 Kinase Is 
Required for PDGFr Trafficking 
The high degree of co-localization of PDGFr and LY, and 
low degree of co-localization with transferrin shown in this 
study (Figs. 1 and 2) suggest that both PDGFr and fluid- 
phase  molecules  enter  the  sorting  endosome,  and  are 
sorted  together  from  recycling  molecules.  The  mecha- 
nisms whereby activated wild-type PDGFr segregate from 
recycling  molecules  and  maintain  a  co-localization  with 
fluid phase markers is not known, but might involve its re- 
tention in  the  vesicular portion of the  sorting endosome 
(10,  11,  22).  Interestingly,  however,  in  contrast  to  wild- 
type PDGFr, F40/51  mutant PDGFr remained dispersed 
in small structures at the cell periphery, and displayed lit- 
tle  co-localization  either  with  LY  or  with  transferrin, 
which localized in more pericentriolar regions.  Similarly, 
in cells treated with wortmannin wild-type PDGFr main- 
tained a  peripheral distribution,  and lost the pronounced 
co-localization with LY observed in nontreated cells (Fig. 
4). These results suggest that in the absence of PI-3 kinase 
activity, PDGFr trafficking is arrested at a very early step 
after  internalization,  before  reaching  the  sorting  endo- 
some.  The  nature  of  the  peripheral  structures  where 
PDGFr are arrested in the  absence of PI-3 kinase is not 
known, but these structures did not display tubulation and 
enlargement in response to wortmannin (not shown), sug- 
gesting they are physically separate  and functionally dif- 
ferent from endosomes containing  transferrin  or Lucifer 
yellow, which tubulate in response to wortmannin. The re- 
sults also support the hypothesis that  the  effect of wort- 
mannin to block PDGFr sorting is independent  of its ef- 
fect on the structure of endosomes containing transferrin 
or LY. 
Potential Mechanisms Involved in the Effects of 
Wortmannin on Organelle Morphology 
As with any other study involving the use of inhibitors, the 
possibility  exists that  this  toxin  may have  direct  targets 
other than PI-3 kinase. In our studies, we observed a close 
temporal correlation between the effects of wortmannin to 
decrease the endogenous levels of Plns(3)P (Table I) and 
to cause changes in organelle morphology (Fig. 7), as well 
as an identical dose-dependency for these effects (not il- 
lustrated).  Wortmannin  had  no  effect  on  the  levels  of 
Plns(4)P or Plns(4,5)P2, and at the concentrations used in 
these studies, wortmannin is not known to directly inhibit 
other protein or lipid kinases. Thus, the results presented 
here suggest, although they do not prove, that the effects 
of wortmannin on organelle morphology are indeed due to 
its inhibitory effect on PI-3 kinase activity. 
Mammalian  PI-3  kinases  catalyze  the  formation  of 
Plns(3)P,  Plns(3,4)P2,  and Plns(3,4,5)P3,  but the specific 
physiological  functions  of  each  of  these  lipids  are  un- 
known. In our studies, low concentrations of wortmannin 
caused a  rapid  and  pronounced decrease in endogenous 
Plns(3)P under conditions of exponential growth. A  simi- 
lar decrease in Plns(3)P occurs under conditions of serum 
starvation  (Duckworth,  B.,  and  L.  Cantley,  unpublished 
results).  Importantly,  the  effects  of  wortmannin  on  or- 
ganelle structure are evident both in exponentially grow- 
ing (Figs. 6 and 7) and in serum-deprived cells (Fig. 4 and 
data not shown). Because Plns(3)P is the only lipid detect- 
able  under both of these  conditions  (Table I; and  refer- 
ence 1), and it decreases in response to wortmannin with a 
time course that closely parallels the appearance of alter- 
ations in endosome morphology (compare Table I and Fig. 
7), it is likely that PI-3 P is the lipid product of PI-3 kinase 
involved in the control of organelle structure. 
PDGF internalization into the lysosomal pathway, which 
is analyzed in serum-starved cells, is closely paralleled by 
the appearance of Plns(3,4)P2  and Plns(3,4,5)P3,  without 
a  detectable increase in Plns(3)P  (1). The appearance of 
both  of  Plns(3,4)P2  and  Plns(3,4,5)P3  in  response  to 
PDGF is thought to result from the recruitment and stimu- 
lation of the pl10/p85 PI-3 kinase isoform to the PDGF re- 
ceptor  cytoplasmic domain.  This  PI-3  kinase  isoform is 
acutely sensitive  to wortmannin,  and  in  fact the  PDGF- 
induced  production  of  Plns(3,4)P2  and  Plns(3,4,5)P3  is 
completely inhibited by wortmannin (Duckworth, B., and 
L. Cantley, personal communication). Thus, either or both 
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PDGFr sorting to the lysosomal pathway. 
The similarity between the effects of wortmannin and 
BFA, consisting mainly in the formation of interconnected 
tubular networks (Figs. 6 and 7 and references 21 and 38), 
suggests that both toxins mayaffect similar targets. The 
targets of BFA appear to include activities that affect the 
exchange of GDP for GTP on ARF1, and thus the activa- 
tion state of this protein (8,  12). Downstream cellular re- 
sponses that are influenced by ARF1 are the binding  of cy- 
tosolic--coat proteins like coatomer (20, 26) and ~/-adaptin 
(29), as well as the activity of phospholipase-D (2, 6). It is 
thought that the changes in organeUe morphology elicited 
by BFA result from the impaired binding of cytosolic-coat 
proteins.  Although  no  specific  cytosolic-coat  proteins 
have been identified in endocytic vesicles, the phenotypic 
responses of these vesicles suggest that such endocytic cy- 
tosolic  coats  exist.  Furthermore,  isoforms  of  ARF  or 
ARF-related GTP-binding proteins in the endoeytic path- 
way may fulfill a function similar to that of ARF1 (7, 27, 
30, 35). 
The effects of wortmannin on endosomes suggest that 
this toxin may affect the assembly of cytosolic-coat com- 
ponents in the endocytic pathway. Furthermore, the find- 
ings that AIF  4-  blocks these effects (Figs. 12 and 13)  is 
consistent with the hypothesis that ALFa--sensitive GTP 
binding proteins  operate in the  endocytic pathway, and 
that these may be regulated by Plns(3)P (Fig. 14). A  role 
for phospholipids in the regulation of the activity of GTP- 
ases  is  consistent  with  recent  reports  which  indicate  a 
marked dependency on phosphoinositides for ARF1 ex- 
change and GAP activities (34, 28). 
An important difference between the  effects of BFA 
and wortmannin is the specificity of wortmannin for or- 
ganelles in the endocytic pathway. BFA causes tubulation 
ICOAT PROTEINS I 
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Figure 14.  Potential targets for PI-3 kinase. Cytosolic coat-pro- 
tein  assembly on membranes is  triggered by  the activation of 
ARF GTPases by factors that catalyze nucleotide exchange. In 
our model, these factors are activated by PI-3 kinase products, 
for example Plns(3)P. The inhibition of PI-3 kinase activity by 
wortmannin results in  a  decrease in  3'-phosphoinositides, and 
thus to inhibition of nucleotide exchange. The process of nucleo- 
tide exchange is  directly inhibited by  BFA.  The  specificity of 
wortmannin for the endocytic pathway may result from the pres- 
ence of PI-3 kinase activities that are less sensitive to the toxin 
which may  be  localized to  the Golgi apparatus  and  other or- 
ganeUes in the secretory pathway. 
of organelles both in the secretory and endocytic path- 
ways, and the former effect is accompanied by inactivation 
of ARF1  and  disassembly of Golgi-specific coats.  The 
specificity of wortmannin for the endocytic pathway does 
not rule out the possibility that PI-3 kinase may operate 
both in the secretory and endocytic pathways to regulate 
coat assembly, as proposed in Fig. 14, because wortmannin 
does not completely deplete the endogenous levels of 3'- 
phosphoinositides. Table I indicates that a significant level 
of PIns(3)P remains in cells after treatment with wortman- 
nin. This may represent the product of PI-3 kinases that 
are less sensitive to wortmannin, which have been previ- 
ously described (32, 33), and which may be localized to the 
Golgi apparatus and/or other organelles in the secretory 
pathway. 
In summary, the results shown here suggest that mam- 
malian PI-3 kinases function at at least two steps in the en- 
docytic pathway. First, PI-3 kinase activity appears to be 
required for the exit of internalized PDGFr from an early 
endocytic intermediate  to  sorting  endosomes  and  later 
steps in the lysosomal degradative pathway. This process 
may require the localized synthesis of higher phosphory- 
lated lipids Plns(3,4)P2 and Pins (3,4,5)P3,  which appear 
upon association of the p85/p110 PI-3 kinase with the cyto- 
plasmic domain of the PDGF receptor (1). A second, inde- 
pendent role of PI-3 kinase may be in maintaining the ve- 
sicular  morphology of endosomes.  It  is  likely that  this 
function requires Plns(3)P, which is the most abundant 3' 
phosphoinositide incells, and is present both in exponen- 
tially  growing  and  serum-deprived  cells.  Because  it  is 
likely that the  maintenance of vesicular organelle mor- 
phology requires cytosolic-coat proteins and the activity 
of specific small GTP-binding proteins, our results suggest 
that downstream targets of PI-3 kinase products may in- 
clude such cellular components. 
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